B01AD07 - Reteplase

Not porphyrinogenic

Rationale

Recombinant enzyme. No CYP-interactions.

Chemical description

Recombinant enzymatic plasmin activator administered as an infusion within 12 hours of a myocardial infarction.

Similar drugs

Explore alternative drugs in similar therapeutic classes B01A / B01AD or go back.

References

Tradenames

Show more details and information about the listed tradenames

Rapilysin

Rapilysin · Retavase

Rapilysin

Ecokinase · Rapilysin

Ecokinase · Rapilysin · Retavase

Reteplasa

Reteplase

In cooperation with Ipnet